Elsevier Announces the Anxiety and Depression: 21st Neuropharmacology Conference

Oxford, 9 March 2011 - Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced that the Anxiety and Depression: 21st Neuropharmacology Annual Conference will take place in Virginia, USA on 10-11 November 2011 as a satellite to the 2011 Meeting of the Society for Neuroscience.

Anxiety and depression are amongst the most common brain disorders, with significant consequences for the individual and society. The 21st Neuropharmacology annual conference will bring together the leading experts in the field of psychiatry, neuroscience and pharmacology to present and discuss the latest research.

The scientific committee composed of acknowledged opinion leaders in anxiety and depression from across the spectrum of research areas will work alongside organizers from Elsevier to develop a multidisciplinary programme.

“The 21st Neuropharmacology Conference on Anxiety and Depression provides researchers with a marvelous opportunity to share knowledge and network with their peers,” said Michael Osuch, executive publisher at Elsevier. 

Among the topics covered at the Anxiety and Depression Conference are: 

• Emerging Therapeutic Targets in Depression
• Emerging Therapeutic Targets in Anxiety
• Animal Models
• Genetics and Epigenetics in Depression and Anxiety
• Imaging
• Developmental Aspects of Anxiety and Depression
• Neuronal Circuits Underlying Anxiety and Depression
• Fear Extinction
• Mechanism of Action of Antidepressants and Anxiolytics

Attendees are welcome to register at  www.neuropharmacology-conference.elsevier.com

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media Contact 
Francesca Webb
+44 (0) 1865 843244